However, CCB (e.g., nifedipine and amlodipine) can worsen gastroesophageal reflux [172] and PDE-5 inhibitors (e.g., sildenafil) can inhibit antral and duodenal motor activity [173]. This evidence concerns the gene PDE5A and gastroesophageal reflux disease.